درباره این اپیزود
Join Kausik Ray for a rapid-fire introduction to the evolving world of cardiovascular prevention. In just a few minutes, discover why cardiovascular disease remains the leading cause of death globally, the key role of cholesterol and cardiometabolic risk factors, and the innovations that could reshape prevention in the years ahead. This episode provides a concise overview of the themes explored throughout the series.
انگلیسی
ایالات متحده آمریکا
رونوشت 🔗
Are you the producer of this podcast?
Add a podcast transcript
Need Audio-to-Text?
Transcribe with Listen411 in Just 60 Seconds
جستجوی اپیزودهای گذشته
اپیزودهای قبلی EMJ Podcast: Insights For Healthcare Professionals را جستجو کن.
قسمت های دیگر در این پادکست
In this episode of Onc Now, Lennard Lee explores the latest advances in personalised cancer vaccines, emerging clinical evidence, and the potential of agentic AI scientists to accelerate cancer discovery, transform drug development and shape the future of oncology.
Timestamps
00:00 - Introductio…
In this episode of Hema Now, we sit down with Toby Eyre, Consultant Haematologist at Oxford University Hospitals, UK, to explore the latest advances in lymphoma and chronic lymphocytic leukaemia, discuss unanswered questions in mantle cell lymphoma, and consider how emerging research is shaping the…
How much do we really understand about modern inflammatory bowel disease (IBD) care? In this quickfire episode, Nuru Noor answers key questions on personalised medicine, treatment success, emerging research, biomarkers, and the growing range of IBD therapies. Discover his perspectives on what the …
How is the treatment paradigm for inflammatory bowel disease changing? Nuru Noor joins host Saranya Ravindran to discuss the impact of the PROFILE trial on Crohn's disease management, the role of early treatment, and the importance of long-term outcomes. This episode explores treat-to-target strat…
This podcast has been funded by Castle Biosciences.
Traditional staging remains the foundation of risk assessment in cutaneous melanoma and cutaneous squamous cell carcinoma (cSCC), but it does not always tell the full story. In T1b–T2a melanoma, the decision on sentinel lymph node biopsy (SLNB) i…
سلب مسئولیت: پادکست و آثار هنری تعبیه شده در این صفحه متعلق به EMJ است که متعلق به صاحب آن است و به Listen Notes، Inc وابسته یا تایید نشده است.
ویرایش
از کمک شما برای بروز نگهداشتن پایگاهدادههای پادکست سپاسگزاریم